Peace and stability as key factors to ASEAN epicentrum of Growth
JAKARTA, Jul 17, 2023 – (ACN Newswire) – Indonesia has completed a series of the…
News
Nukem Loans (“$NUKEM”) to Deploy a Lending Market for Floki (FLOKI) Coin
RAS AL KHAIMAH, United Arab Emirates, July 16, 2023 (GLOBE NEWSWIRE) — Nukem Loans, an…
Nukem Loans (“$NUKEM”) to Deploy a Lending Market for Volt Inu (VOLT) Coin
RAS AL KHAIMAH, United Arab Emirates, July 16, 2023 (GLOBE NEWSWIRE) — Nukem Loans, an…
Nukem Loans (“$NUKEM”) to Deploy a Lending Market for Capo (CAPO) Coin
RAS AL KHAIMAH, United Arab Emirates, July 16, 2023 (GLOBE NEWSWIRE) — Nukem Loans, an…
Nukem Loans (“$NUKEM”) to Deploy a Lending Market for Blue (BLUE) Coin
RAS AL KHAIMAH, United Arab Emirates, July 16, 2023 (GLOBE NEWSWIRE) — Nukem Loans, an…
Nukem Loans (“$NUKEM”) to Deploy a Lending Market for Katana Inu (KATA) Coin
RAS AL KHAIMAH, United Arab Emirates, July 16, 2023 (GLOBE NEWSWIRE) — Nukem Loans, an…
GMAC Intelligence Goes Big with BrainChip Partnership
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first…
Nukem Loans (“$NUKEM”) To Launch
RAS AL KHAIMAH, United Arab Emirates, July 16, 2023 (GLOBE NEWSWIRE) — Nukem Loans, an…
Nukem Loans (“$NUKEM”) to Deploy a Lending Market for BabyDoge (BABYDOGE) Coin
RAS AL KHAIMAH, United Arab Emirates, July 16, 2023 (GLOBE NEWSWIRE) — Nukem Loans, an…
Energix Renewables, First Solar Enter into Framework Agreement
Modules to be delivered between 2026 and 2030 for projects in Israel, Poland, and US…
Vivoryon Therapeutics N.V. Shares Clinical Development Update Highlighting Progress of N3pE-Amyloid-targeting Small Molecule Varoglutamstat in Alzheimer’s Disease
Vivoryon Therapeutics N.V. Shares Clinical Development Update Highlighting Progress of N3pE-Amyloid-targeting Small Molecule Varoglutamstat in…
Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease at the Alzheimer’s Association International Conference (AAIC) 2023
Figure 1 Acumen Pharmaceuticals, Inc. Figure 2 Acumen Pharmaceuticals, Inc. Topline results from INTERCEPT-AD trial…
Law Office of Shira J Stefanik Announces New Belltown DUI Legal Defense Service
Seattle, Washington–(Newsfile Corp. – July 15, 2023) – Pioneer Square -based Law Office of Shira…
Biora Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update
SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023
HAMILTON, Bermuda, July 18, 2023 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today…
Rhythm Pharmaceuticals to Report Second Quarter 2023 Financial Results on Tuesday, August 1, 2023
BOSTON, July 18, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company…
LEX Diagnostics Appoints Chief Technology Officer
CAMBRIDGE, United Kingdom, July 18, 2023 (GLOBE NEWSWIRE) — LEX Diagnostics (LEX) today announces the…
C4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WATERTOWN, Mass., July 17, 2023 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a…
Elektrofi Appoints Victoria Sluzky as Chief Technical Officer to Drive Innovation and Technical Excellence
BOSTON, July 17, 2023 (GLOBE NEWSWIRE) — Today Elektrofi, a biopharmaceutical formulation technology company focused…
Panbela Announces Issuance of New Patent in Australia Patent is for Claims of a Novel Process for the Production of SBP-101
Patent developed in collaboration with Syngene International Ltd. MINNEAPOLIS, July 17, 2023 (GLOBE NEWSWIRE) —…